Girard Sharp is investigating potential securities claims on behalf of former investors of Ansys, Inc. (“Ansys”) who received shares of Synopsys, Inc. (“Synopsys” or the “Company”) in connection with Synopsys’s acquisition of Ansys on July 17, 2025 (“Merger”).

If you are a former Ansys investor who received Synopsys shares in the July 2025 Merger, you may have a claim for relief.

Speak to a Girard Sharp attorney about your rights and your eligibility for relief. Please fill out our form or call (866) 981-4800 for a free consultation.

Synopsys Stock Drops Drastically After July Merger 

Synopsys, headquartered in Sunnyvale, California, is a leading provider of electronic design automation software products used to design and test integrated circuits. Synopsys states that it “is a valued partner for global silicon to systems design across a wide range of vertical markets, empowering technology innovators everywhere with the industry’s most comprehensive and trusted solutions.” On September 9, 2025, Synopsys reported that its “IP business underperformed expectations.” When investors learned of these third quarter 2025 financial results, Synopsys’s stock price fell dramatically.

Our Commitment to Excellence

Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We recently obtained a $36.5 million securities settlement against Maxar Technologies, a space imagery company, after its share price collapsed following its acquisition of DigitalGlobe. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.